PharmaShots Weekly Snapshots (Feb 15- 19, 2021)
RedHill Signs a Manufacturing Agreement with Cosmo for Movantik and RHB-204
Published: Feb 19, 2021 | Tags: RedHill, Signs, Manufacturing, Agreement, Cosmo, Movantik, RHB-204
Published: Feb 19, 2021 | Tags: Astellas, Seagen, Reports, Submission, Two, BLA, US, FDA, Padcev (enfortumab vedotin), Locally, Advanced, Metastatic, Urothelial Cancer
Published: Feb 19, 2021 | Tags: US, FDA, Approves, Patient, Specific, Talus Spacer, Treat, AVN, Ankle Joint, Humanitarian, Use, Device
Published: Feb 19, 2021 | Tags: Dermavant, Report, Results, Tapinarof Cream, P-III, PSOARING 3, Study, Durable, Remittive Benefits, Plaque Psoriasis
Published: Feb 19, 2021 | Tags: Fresenius Kabi, Launches, Idacio (biosimilar, adalimumab), Multiple Chronic Inflammatory, Conditions, Canada
Published: Feb 19, 2021 | Tags: Lilly, Collaborates, Rigel, Develop, RIPK1 Inhibitors, Immunological , Neurodegenerative Diseases
Published: Feb 18, 2021 | Tags: BeiGene, Reports, US, FDA, Acceptance, sNDA, Brukinsa (zanubrutinib), Waldenström's Macroglobulinemia
Published: Feb 18, 2021 | Tags: Myovant, Pfizer, Publish, Results, Relugolix, Combination, Regimen ,P-III, LIBERTY, Studies, NEJM
Published: Feb 18, 2021 | Tags: GSK, Expand, 2020, Collaboration, Vir, Advance, New, Therapies, Influenza, Other, Respiratory, Viruses
Published: Feb 18, 2021 | Tags: Novartis, Collaborates, Bill & Melinda, Gates Foundation, Discover ,Develop, Gene Therapy, Sickle Cell Disease
Lilly Reports Results of Tirzepatide in P-lll SURPASS-3 and 5 Trials for Type-2 Diabetes
Published: Feb 18, 2021 | Tags: Lilly, Reports, Results, Tirzepatide, P-lll, SURPASS-3 and 5, Trials, Type-2 Diabetes
Coherus Reports the US FDA's Acceptance of BLA for CHS-1420 (biosimilar, adalimumab)
Published: Feb 18, 2021 | Tags: Coherus, Reports, US, FDA, Acceptance, BLA, CHS-1420 (biosimilar, adalimumab)
Boehringer Ingelheim Animal Health Establishes Pawru for its PetPro Portfolio
Published: Feb 17, 2021 | Tags: Boehringer Ingelheim, Animal Health, Establishes, Pawru, PetPro Portfolio
Novartis's Entresto Receives US FDA's Approval for Chronic Heart Failure
Published: Feb 17, 2021 | Tags: Novartis, Entresto, Receives, US, FDA, Approval, Chronic Heart Failure
GSK Initiates P-III study for RSV Candidate Vaccine Programme for Older Adults
Published: Feb 17, 2021 | Tags: GSK, Initiates, P-III study, RSV, Candidate, Vaccine, Programme, Older, Adults
Novartis Report Results of Kesimpta (ofatumumab) Sensoready Autoinjector Pen for Multiple Sclerosis
Published: Feb 17, 2021 | Tags: Novartis, Report, Results, Kesimpta (ofatumumab), Sensoready, Autoinjector Pen, Multiple Sclerosis
Published: Feb 17, 2021 | Tags: BMS and Acceleron, Reblozyl (Luspatercept), Receives, Health Canada, Approval, Adult Patients, Myelodysplastic Syndromes
Guardant Health Launches Guardant Reveal Liquid Biopsy Test for Early-Stage Colorectal Cancer
Published: Feb 17, 2021 | Tags: Guardant Health, Launches, Guardant Reveal, Liquid, Biopsy Test, Early Stage, Colorectal Cancer
Published: Feb 16, 2021 | Tags: Onward, Signs, Worldwide, Exclusive, License, Co-Development ,Agreement, Biomunex, Immuno-Oncology
Published: Feb 16, 2021 | Tags: Aker BioMarine, Collaborate, Université de Sherbrooke, Department, Medicine, Alzheimer's Disease
AstraZeneca and Serum Institute of India's COVID-19 Vaccine Receive WHO's EUA to Prevent COVID-19
Published: Feb 16, 2021 | Tags: AstraZeneca and Serum Institute of India, COVID-19 Vaccine, Receive ,WHO, EUA, Prevent, COVID-19
Targovax Receives US FDA's Fast Track Designation for ONCOS-102 for Malignant Pleural Mesothelioma
Published: Feb 16, 2021 | Tags: Targovax, Receives, US, FDA, Fast Track Designation, ONCOS-102, Malignant Pleural Mesothelioma
Published: Feb 16, 2021 | Tags: Celltrion, Receives, EC, Approval, Yuflyma (biosimilar, adalimumab), Treatment, Multiple Chronic Inflammatory, Diseases
Published: Feb 16, 2021 | Tags: Exelixis, Report, Results, Cabometyx (cabozantinib), P-II, PAPMET Study, Patients, Metastatic, Papillary, Renal Cell Carcinoma
Roche's Receives the US FDA's Clearance for Urine Sample Type for BK Virus Quantitative Test
Published: Feb 15, 2021 | Tags: Roche, Receives, US, FDA, Clearance, Urine Sample, Type, BK Virus, Quantitative Test
Published: Feb 15, 2021 | Tags: Biocon Biologics and Viatris, Receive, EC, Approval, Kixelle (biosimilar, insulin aspart), Diabetes Mellitus
Published: Feb 15, 2021 | Tags: Merck, Report, Result, Keytruda (pembrolizumab) + Lenvima (lenvatinib), 1L, Treatment, Advanced Renal Cell Carcinoma
Published: Feb 15, 2021 | Tags: Pfizer, Panzyga, Receives, US, FDA, Approval, sBLA, Chronic Inflammatory, Demyelinating, Polyneuropathy
Published: Feb 15, 2021 | Tags: Takeda, Report, Results, TAK-620 (maribavir), P-III, SOLCTICE Trial, Treatment, Post Transplant, Patients, Cytomegalovirus Infection
Published: Feb 15, 2021 | Tags: G1 Therapeutics, Cosela (trilaciclib), Receives, US, FDA, Approval, First, Myeloprotection, Therapy, Extensive Stage, Small Cell, Lung Cancer
Related post: PharmaShots Weekly Snapshots (Feb 08 - 12, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com